cost of glp-1 agonists Antagonists Increase Plan Drug Spend - What's Next How Employers Can Optimize Benefits

[DOI] [PMC free article] [PubMed] [Google Scholar] 133.Banerjee M, Maisnam I, Pal R, Mukhopadhyay S

issued a statement from Soumi Saha, senior vice president for government affairs, saying the company is gratified to see CMS crack down on plans ability to retroactively deny approved hospital stays. MA appeals rights are being strengthened through provisions clarifying that coverage determinations are subject to notification requirements and subsequent appeal if they take place during concurrent review of inpatient admissions

Synonyms Plantago major , Plantago lanceolata , Plantago psyllium , and Plantago arenaria

In short, they found that while consumers, employers and physicians are optimistic about the effectiveness of GLP-1s to treat obesity, cost and coverage are significant hurdles for consumer access

A.GhoshP.PesapaneA.TaktazF.PuocciA.FranzeseM.et al (2024)

Kreutter, D